Tidal Vision completes $140M Series B to Scale Chitosan Technologies Globally

潮汐视觉完成1.4亿美元B轮融资，以推动壳聚糖技术全球化发展

Funding Fuels Global Expansion with New Facilities that Strengthen Supply of Chitosan Chemistries.

资金助力全球扩展，新建设施增强壳聚糖化学品的供应。

BELLINGHAM, Wash., February 5, 2025-- Tidal Vision, a biotechnology company transforming critical industries with chitosan-based chemistries, announced the closing of an oversubscribed $140M Series B financing round. The round exceeded its original target due to demand from strategically aligned investors including Cambridge Companies SPG, Eni Next (the corporate venture arm of Eni S.p.A), Milliken & Company, KIRKBI Climate, Convent Capital, SWEN Capital Partners' Blue Ocean Fund, MBX Capital, Oman Investment Authority's IDO Investments, and more..

华盛顿州贝灵汉，2025年2月5日——Tidal Vision，一家利用壳聚糖化学改造关键行业的生物技术公司，宣布完成了超额认购的1.4亿美元B轮融资。本轮融资由于来自战略投资者的需求，超出了原定目标，投资者包括Cambridge Companies SPG、Eni Next（Eni S.p.A的企业风险投资部门）、Milliken & Company、KIRKBI Climate、Convent Capital、SWEN Capital Partners的Blue Ocean Fund、MBX Capital、阿曼投资管理局的IDO Investments等。

This financing fuels Tidal Vision's ability to continuously increase the performance, economics, and ease of adoption of chitosan-based solutions with greater production capacities and expanded research and development resources. The company is building new infrastructure in Europe, Texas, and Ohio, further expanding its footprint.

此次融资为Tidal Vision提供了持续提升壳聚糖基解决方案性能、经济性和易用性的能力，同时增加了生产能力和研发资源。公司正在欧洲、德克萨斯和俄亥俄州建设新的基础设施，进一步扩大其业务版图。

Resources will also be invested in accelerating R&D in chitosan and adjacent technologies, adding to the company's already impressive intellectual property portfolio. With a greater number of both commercial-scale and R&D facilities around the world, Tidal Vision will make chitosan-based solutions more accessible to customers globally..

资源也将投入于加速壳聚糖及相关技术的研发，进一步丰富公司已有的令人印象深刻的知识产权组合。随着全球范围内更多商业规模和研发设施的建立，Tidal Vision将使壳聚糖解决方案更容易被全球客户所获取。

'We are thrilled to have these strategically aligned capital partners onboard and supportive of accelerating our mission,' said Craig Kasberg, CEO of Tidal Vision. 'We've already demonstrated it's possible to make our biomolecular solutions outcompete. Now, we're building infrastructure that'll allow us to better serve customers who operate in critical industries providing the clean water, agriculture production, and materials necessary for everyday life.'.

“我们非常高兴能与这些战略上一致的资金伙伴合作，他们支持我们加速实现使命，”Tidal Vision的首席执行官Craig Kasberg说。“我们已经证明了我们的生物分子解决方案具有竞争优势。现在，我们正在建设基础设施，以便更好地服务于那些在关键行业运营的客户，这些行业提供清洁水、农业生产以及日常生活所需的材料。”

'We're pleased to have led this $140M Series B growth equity round for Tidal Vision,' said Filipp Chebotarev, Managing Partner and Chief Operating Officer at Cambridge Companies SPG. 'Tidal Vision is the global leader in chitosan extraction, modification, characterization, and commercial applications.

“我们很高兴能够领投Tidal Vision这轮1.4亿美元的B轮增长股权融资，”剑桥公司SPG的管理合伙人兼首席运营官Filipp Chebotarev表示。“Tidal Vision在壳聚糖提取、改性、表征和商业应用领域处于全球领先地位。”

These important investments will enable Tidal Vision to continue to apply these crucial scientific breakthrough technologies commercially across a variety of sectors.'.

这些重要的投资将使Tidal Vision能够继续将这些关键的科学突破技术商业化应用于多个领域。

About Tidal Vision:

关于Tidal Vision：

Tidal Vision is a global leader in scalable biomolecular solutions for critical industries, such as water treatment, agriculture, and material science. Our mission is to create positive and systemic environmental impact. We're building a world where chitosan-based technologies are more economical, better performing, and easier to adopt.

Tidal Vision 是全球领先的可扩展生物分子解决方案提供商，服务于水处理、农业和材料科学等关键行业。我们的使命是创造积极且系统性的环境影响。我们致力于构建一个世界，使基于壳聚糖的技术更加经济、性能更优且更易于采用。

We invite the leaders of modern industry to join us in creating systemic impact globally..

我们邀请现代工业的领导者们与我们一起在全球范围内创造系统性影响。

Learn more at www.TidalVision.com and on LinkedIn.

了解更多信息，请访问 www.TidalVision.com 和 LinkedIn。